| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2015-03-05 16:53:32 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm will hold Fourth Quarter 2014 Investor Conference WebinarAS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its fourth quarter 2014 investor conference webinar scheduled on March 11, 2015 at 16:00 (EET). Please note that the registration process for the webinar has been changed – detailed information can be found below. Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities and analyze the financial results of the fourth quarter 2014 and non-audited financial results of 12 months 2014. After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance till March 10 to e-mail: ieva.kadakovska@nasdaq.com or Investors’ portal naudaslietas.lv.
What is
webinar? How to join the
webinar? To join the webinar, we invite you to register via http://ej.uz/OLF_Q4_2014. You will be provided with the
webinar link and instructions to join webinar successfully. When
joining the webinar for the first time, you will be asked to
download the system application on your computer which will take
only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia Information
prepared by: |
| Pielikumi |
|